Publication: Chroman amide and nicotinyl amide derivatives: Inhibition of lipid peroxidation and protection against head trauma
1
Issued Date
2000-01-01
Resource Type
ISSN
10715762
Other identifier(s)
2-s2.0-0033967295
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Free Radical Research. Vol.32, No.2 (2000), 145-155
Suggested Citation
Opa Vajragupta, Suwanna Toasaksiri, Chantana Boonyarat, Yuvadee Wongkrajang, Penchom Peungvicha, Hiroshi Watanabe, Preecha Boonchoong Chroman amide and nicotinyl amide derivatives: Inhibition of lipid peroxidation and protection against head trauma. Free Radical Research. Vol.32, No.2 (2000), 145-155. doi:10.1080/10715760000300151 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/25888
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Chroman amide and nicotinyl amide derivatives: Inhibition of lipid peroxidation and protection against head trauma
Other Contributor(s)
Abstract
A series of chroman amide and nicotinyl amide derivatives was designed and synthesized for the treatment of traumatic and ischemic CNS injury. Five compounds were significantly more potent inhibitors of lipid peroxidation in vitro than the reference antioxidant, trolox (p<0.01). Quantitative structure activity studies demonstrated that the inhibitory action was related to the ability to donate electrons, charge on hydroxy group and E(LUMO), to scavenging radicals and to the lipophilicity log P, which determines penetration of membrane lipids. ESR study indicated the ability, of 12 to scavenge the hydroxyl radicals. The most promising compound, [(3,4-dihydro-6- hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2yl)carbonyl]3'-(aminoethyl) indole (12), inhibited ex vivo lipid peroxidation in a head injury model and showed potent in vivo neuroprotective efficacy. Improvement of neurological recovery within 1 h of injury (grip test score) by as much as 200% was observed together with significant anti-anoxia activity. Compound 12 was a potent antagonist of methamphetamine-induced hypermotility resulting from dopamine release in the mouse brain. These results support the importance of cerebroprotective radical-scavenging agents for the treatment of traumatic injury and anoxia as well as provide additional evidence for the role of oxygen radicals and dopamine in brain damage.